Sympathoinhibitory signals from the gut and obesity-related hypertension

被引:0
|
作者
Daniela M. Sartor
机构
[1] University of Melbourne,Clinical Pharmacology and Therapeutics Unit, Department of Medicine
[2] Austin Health,undefined
来源
关键词
Sympathetic nervous system; Cholecystokinin; Leptin; Obesity; Hypertension; Cardiovascular;
D O I
暂无
中图分类号
学科分类号
摘要
Several gastrointestinal hormones are commonly associated with satiety and digestion, but recent studies suggest they are also involved in regulating hemodynamic demand after a meal. These hormones released from the gut postprandially play a role in short-term cardiovascular regulation via a vagally mediated sympathoinhibitory reflex mechanism, similar to that of the arterial baroreflex. It has been hypothesized that activation of this reflex may promote greater blood flow to the splanchnic and renal vasculature that have increased haemodynamic demand after a meal, while simultaneously inducing vasoconstriction to the skeletomuscular vasculature where it is needed less. Together, the renal and splanchnic circulations can command over 50 % of cardiac output so that the role of gut hormones in controlling sympathetic vasomotor tone to these vascular beds may be more important in cardiovascular regulation than previously thought. The exact aetiology of obesity-related hypertension remains to be determined and is likely to be multifactorial, although the involvement of gut hormone signalling in the development of this disease has not previously been considered. Diets rich in fats and increased food intake are amongst the leading causes of obesity and precipitate significant changes such as inflammation in the gastrointestinal environment that can lead to blunted vagal afferent signalling. In obesity, these changes may disrupt sympathoinhibitory mechanisms and subsequently lead to increased vascular resistance in the gastrointestinal and renal vascular beds, contributing to the development of hypertension.
引用
收藏
页码:33 / 39
页数:6
相关论文
共 50 条
  • [41] Effect of diabetes and hypertension on obesity-related mortality
    Livingston, EH
    Ko, CY
    [J]. SURGERY, 2005, 137 (01) : 16 - 25
  • [42] Recent developments in the treatment of obesity-related hypertension
    Pischon, T
    Sharma, AM
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (05): : 497 - 502
  • [43] Treatment of Obesity-Related Hypertension in Children and Adolescents
    Susan M. Halbach
    Joseph Flynn
    [J]. Current Hypertension Reports, 2013, 15 : 224 - 231
  • [44] Highlights of mechanisms and treatment of obesity-related hypertension
    Shams, Elham
    Kamalumpundi, Vijayvardhan
    Peterson, Joshua
    Gismondi, Ronaldo Altenburg
    Oigman, Wille
    de Gusmao Correia, Marcelo Lima
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2022, 36 (09) : 785 - 793
  • [45] THE ZUCKER RAT AS A MODEL OF OBESITY-RELATED HYPERTENSION
    KURTZ, TW
    MORRIS, RC
    PERSHADSINGH, HA
    [J]. HYPERTENSION, 1988, 12 (03) : 354 - 354
  • [46] Correlation between obesity-related indices and hypertension
    Zhao, Guangyi
    Zhou, Zhiyi
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (08): : 3842 - 3850
  • [47] Uric acid level is one of the predictors of hypertension, obesity and obesity-related hypertension
    Masuo, K
    Mikami, H
    Ogihara, T
    Tuck, ML
    [J]. HYPERTENSION, 2002, 40 (03) : 385 - 385
  • [48] Pathophysiological role of leptin in obesity-related hypertension
    Aizawa-Abe, M
    Ogawa, Y
    Masuzaki, H
    Ebihara, K
    Satoh, N
    Iwai, H
    Matsuoka, N
    Hayashi, T
    Hosoda, K
    Inoue, G
    Yoshimasa, Y
    Nakao, K
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09): : 1243 - 1252
  • [49] Highlights of mechanisms and treatment of obesity-related hypertension
    Elham Shams
    Vijayvardhan Kamalumpundi
    Joshua Peterson
    Ronaldo Altenburg Gismondi
    Wille Oigman
    Marcelo Lima de Gusmão Correia
    [J]. Journal of Human Hypertension, 2022, 36 : 785 - 793
  • [50] Hyperleptinemia as a risk factor in obesity-related hypertension
    Alvarez-Aguilar, C
    Mondragón-Jiménez, LI
    Ramírez-Enríquez, J
    Gómez-García, A
    Paniagua-Sierra, R
    Amato, D
    [J]. MEDICINA CLINICA, 2004, 123 (20): : 766 - 769